Genzyme gets European nod for US manufacturing site
This article was originally published in Scrip
Executive Summary
Genzyme (Sanofi) has obtained European Medicines Agency (EMA) approval of its manufacturing plant in Framingham, Massachusetts, for the production of Fabrazyme (agalsidase beta).